paraoxon has been researched along with Disease Models, Animal in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (23.81) | 29.6817 |
| 2010's | 12 (57.14) | 24.3611 |
| 2020's | 3 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Lenina, OA; Petrov, KA | 1 |
| Bar-Klein, G; Eisenkraft, A; Friedman, A; Kamintsky, L; Prager, O; Rosman, Y; Serlin, Y; Shrot, S; Statlender, L; Swissa, E; Weissberg, I | 1 |
| Lenina, OA; Masson, P; Petrov, KA; Semenov, VE; Zobov, VV; Zueva, IV | 1 |
| Appu, AP; Arun, P; Braga, MF; Figueiredo, TH; Flagg, T; Krishnan, JKS; Moffett, JR; Namboodiri, AM; Puthillathu, N | 1 |
| Al-Barazie, RM; Al-Ramadi, BK; Al-Sbiei, A; Bashir, GH; Fernandez-Cabezudo, MJ; Lammers, WJ; Mohamed, YA; Qureshi, MM; Tariq, S | 1 |
| Al-Mansori, A; Al-Ramadi, BK; Bashir, G; Fernández-Cabezudo, MJ; George, JA; Lorke, DE; Mohamed, YA; Petroianu, G; Qureshi, MM | 1 |
| Jona, G; Mohar, B; Ruban, A; Teichberg, VI | 1 |
| Blair, RE; Carter, DS; DeLorenzo, RJ; Deshpande, LS; Phillips, KF | 1 |
| Bar-Klein, G; Bialer, M; Eisenkraft, A; Friedman, A; Hubary, Y; Kamintsky, L; Saar-Ashkenazy, R; Shekh-Ahmad, T; Shrot, S; Stetlander, L; Swissa, E | 1 |
| Liu, J; Pope, C | 1 |
| Cohen, Y; Eisenkraft, A; Kadar, T; Kassirer, M; Milk, N; Rosman, Y; Shiyovich, A; Shrot, S; Tauber, M | 1 |
| Baker, AA; Heck, DE; Jan, YH; Laskin, DL; Laskin, JD; Mishin, V; Richardson, JR | 1 |
| Ambert, N; Barbier, L; Baudry, M; Bischoff, S; Bouteiller, JM; Dadak, S; Dorandeu, F; Fagni, L; Greget, R; Lauga, F; Legendre, A; Linossier-Pierre, S; Moussaoui, S; Pernot, F | 1 |
| Bankstahl, JP; Bankstahl, M; Bar-Klein, G; Bascuñana, P; Brandt, C; Dalipaj, H; Friedman, A; Klee, R; Löscher, W; Töllner, K | 1 |
| Baud, FJ; Debray, M; Houzé, P; Kayouka, M | 1 |
| Cole, TB; Costa, LG; Furlong, CE; Jansen, K; Li, WF; Park, S | 1 |
| Bełtowski, J; Jamroz, A; Wójcicka, G | 1 |
| Ben-Ari, S; Ben-Shaul, Y; Benmoyal-Segal, L; Bergman, H; Soreq, H | 1 |
| Dirican, M; Sarandöl, E; Taş, S | 1 |
| Goodkin, HR; Joshi, S; Kapur, J; Kozhemyakin, M | 1 |
| Dettbarn, WD; Wecker, L | 1 |
1 review(s) available for paraoxon and Disease Models, Animal
| Article | Year |
|---|---|
The toxicity of mixtures of specific organophosphate compounds is modulated by paraoxonase 1 status.
Topics: Animals; Aryldialkylphosphatase; Carboxylesterase; Chlorpyrifos; Disease Models, Animal; Genotype; Insecticides; Mice; Mice, Knockout; Organophosphorus Compounds; Paraoxon; Tissue Distribution | 2010 |
20 other study(ies) available for paraoxon and Disease Models, Animal
| Article | Year |
|---|---|
Balanced modulation of neuromuscular synaptic transmission via M1 and M2 muscarinic receptors during inhibition of cholinesterases.
Topics: Animals; Antidotes; Atropine; Cholinesterase Inhibitors; Cholinesterases; Diamines; Diaphragm; Disease Models, Animal; Mice; Muscarinic Antagonists; Muscle Contraction; Muscle Weakness; Paraoxon; Parasympatholytics; Pirenzepine; Protective Agents; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Signal Transduction; Synaptic Transmission; Treatment Outcome | 2022 |
Midazolam and isoflurane combination reduces late brain damage in the paraoxon-induced status epilepticus rat model.
Topics: Animals; Anticonvulsants; Brain; Disease Models, Animal; Isoflurane; Male; Midazolam; Paraoxon; Rats, Sprague-Dawley; Status Epilepticus | 2020 |
Slow-binding reversible inhibitor of acetylcholinesterase with long-lasting action for prophylaxis of organophosphate poisoning.
Topics: Animals; Benzylammonium Compounds; Bromides; Cholinesterase Inhibitors; Delayed-Action Preparations; Disease Models, Animal; Mice; Organophosphate Poisoning; Organophosphorus Compounds; Paraoxon; Pyridostigmine Bromide; Time Factors | 2020 |
Brief isoflurane administration as a post-exposure treatment for organophosphate poisoning.
Topics: Amygdala; Anesthetics, Inhalation; Animals; Cholinesterase Inhibitors; Cholinesterase Reactivators; Disease Models, Animal; Follow-Up Studies; Hippocampus; Isoflurane; Male; Obidoxime Chloride; Organophosphate Poisoning; Paraoxon; Rats; Rats, Sprague-Dawley; Time Factors | 2017 |
Cholinergic Activation Enhances Resistance to Oral
Topics: Acetylcholinesterase; Administration, Oral; Animals; Bacterial Load; Cell Degranulation; Cells, Cultured; Cholinergic Agonists; Cholinesterase Inhibitors; Cytokines; Disease Models, Animal; Humans; Ileum; Immunity, Innate; Intestinal Mucosa; Male; Mice; Mice, Inbred BALB C; Neuroimmunomodulation; Paraoxon; Salmonella typhi; Typhoid Fever | 2018 |
Involvement of Acetylcholine Receptors in Cholinergic Pathway-Mediated Protection Against Autoimmune Diabetes.
Topics: Acetylcholinesterase; Animals; Atropine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; GPI-Linked Proteins; Hyperglycemia; Insulin-Secreting Cells; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Muscarinic Antagonists; Nicotinic Antagonists; Paraoxon; Receptors, Muscarinic; Receptors, Nicotinic; Streptozocin | 2019 |
Blood glutamate scavenging as a novel neuroprotective treatment for paraoxon intoxication.
Topics: Animals; Aspartate Aminotransferases; Brain Injuries; Carrier Proteins; Cerebral Cortex; Cholinesterase Inhibitors; Disease Models, Animal; Hep G2 Cells; Humans; Male; Neurons; Oxaloacetic Acid; Paraoxon; Rats; Rats, Sprague-Dawley; Receptors, GABA-A | 2014 |
Development of status epilepticus, sustained calcium elevations and neuronal injury in a rat survival model of lethal paraoxon intoxication.
Topics: Animals; Anticonvulsants; Atropine; Brain; Calcium; Diazepam; Disease Models, Animal; Electroencephalography; Hippocampus; Male; Neurons; Organophosphate Poisoning; Paraoxon; Pralidoxime Compounds; Rats; Rats, Sprague-Dawley; Status Epilepticus | 2014 |
sec-Butyl-propylacetamide (SPD) and two of its stereoisomers rapidly terminate paraoxon-induced status epilepticus in rats.
Topics: Amides; Animals; Anticonvulsants; Disease Models, Animal; Electroencephalography; Insecticides; Male; Paraoxon; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric; Status Epilepticus; Stereoisomerism; Treatment Outcome; Valproic Acid | 2014 |
The cannabinoid receptor antagonist AM251 increases paraoxon and chlorpyrifos oxon toxicity in rats.
Topics: Amidohydrolases; Analysis of Variance; Animals; Arachidonic Acids; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Chlorpyrifos; Cholinesterase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Endocannabinoids; Insecticides; Male; Monoacylglycerol Lipases; Neurotoxicity Syndromes; Paraoxon; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Sprague-Dawley; Time Factors; Tritium | 2015 |
Early brain magnetic resonance imaging can predict short and long-term outcomes after organophosphate poisoning in a rat model.
Topics: Animals; Aspartic Acid; Atropine; Behavior, Animal; Brain; Brain Edema; Choline; Cholinesterase Reactivators; Cognition; Creatine; Disease Models, Animal; Drug Therapy, Combination; Early Diagnosis; Magnetic Resonance Imaging; Male; Maze Learning; Midazolam; Neuroprotective Agents; Obidoxime Chloride; Organophosphate Poisoning; Paraoxon; Predictive Value of Tests; Proton Magnetic Resonance Spectroscopy; Rats, Sprague-Dawley; Scopolamine; Time Factors; Weight Loss | 2015 |
Vitamin K3 (menadione) redox cycling inhibits cytochrome P450-mediated metabolism and inhibits parathion intoxication.
Topics: Acetylcholinesterase; Activation, Metabolic; Animals; Cholinesterase Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Female; GPI-Linked Proteins; Humans; Insecticides; Liver; Microsomes, Liver; NADP; Organophosphate Poisoning; Oxidation-Reduction; Paraoxon; Parathion; Rats, Long-Evans; Recombinant Proteins; Time Factors; Vitamin K 3 | 2015 |
Modeling and simulation of organophosphate-induced neurotoxicity: Prediction and validation by experimental studies.
Topics: Acetylcholinesterase; Animals; Brain Waves; Cholinesterase Reactivators; Computer Simulation; Disease Models, Animal; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Hippocampus; Male; Memantine; Membrane Potentials; Mice; Models, Neurological; Neurons; Neurotoxicity Syndromes; Organophosphates; Oximes; Paraoxon; Pyridinium Compounds | 2016 |
Isoflurane prevents acquired epilepsy in rat models of temporal lobe epilepsy.
Topics: Animals; Blood-Brain Barrier; Disease Models, Animal; Electrocorticography; Epilepsy, Temporal Lobe; Female; Inflammation; Isoflurane; Kainic Acid; Magnetic Resonance Imaging; Male; Neuroimaging; Neurons; Paraoxon; Positron-Emission Tomography; Rats | 2016 |
Acute renal failure enhances the antidotal activity of pralidoxime towards paraoxon-induced respiratory toxicity.
Topics: Acute Kidney Injury; Animals; Antidotes; Disease Models, Animal; Insecticides; Lethal Dose 50; Male; Paraoxon; Plethysmography, Whole Body; Pralidoxime Compounds; Rats; Rats, Sprague-Dawley; Respiration; Respiration Disorders | 2009 |
Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Antimetabolites, Antineoplastic; Antioxidants; Aryldialkylphosphatase; Biomarkers; Cholinesterase Inhibitors; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperlipidemias; Isoprostanes; Lactones; Leptin; Male; Models, Cardiovascular; Oxidative Stress; Paraoxon; Phenylacetates; Rats; Rats, Wistar; Statistics as Topic | 2003 |
Adaptive acetylcholinesterase splicing patterns attenuate 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Behavior, Animal; Brain; Cell Count; Cholinesterase Inhibitors; Corticosterone; Disease Models, Animal; Disease Progression; Drug Synergism; Exploratory Behavior; Humans; Immunohistochemistry; Male; Mice; Mice, Transgenic; MPTP Poisoning; Paraoxon; RNA Splicing; Synapses; Tyrosine 3-Monooxygenase | 2006 |
High-dose taurine supplementation increases serum paraoxonase and arylesterase activities in experimental hypothyroidism.
Topics: Animals; Antioxidants; Aryldialkylphosphatase; Carboxylic Ester Hydrolases; Cholesterol; Cholesterol, HDL; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Drug; Hypothyroidism; Lipid Peroxidation; Male; Malondialdehyde; Paraoxon; Phenylacetates; Propylthiouracil; Rats; Rats, Sprague-Dawley; Taurine; Triglycerides; Up-Regulation | 2007 |
Impact of receptor changes on treatment of status epilepticus.
Topics: Action Potentials; Animals; Benzodiazepines; Cholinesterase Inhibitors; Disease Models, Animal; Drug Resistance; Excitatory Postsynaptic Potentials; gamma-Aminobutyric Acid; Humans; Male; Paraoxon; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Seizures; Status Epilepticus; Synaptic Transmission | 2007 |
Effects of denervation on the production of an experimental myopathy.
Topics: Animals; Choline O-Acetyltransferase; Cholinesterases; Diaphragm; Disease Models, Animal; Male; Muscle Denervation; Muscular Diseases; Paraoxon; Rats; Time Factors | 1977 |